Amanda Jackson - Concepedia

Author

Amanda Jackson

University of North Carolina at Chapel Hill ORCID

Also Known As

A Jackson, A. Jackson, A. L. Jackson, A.L. Jackson, Amanda Jackson, Amanda L Jackson, Amanda L. Jackson, Amanda Lynn Jackson, Ariana L. Jackson, Ariyan Jackson

149

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill University of Cincinnati University of Cincinnati Medical Center Shandong Tumor Hospital Shandong First Medical University

About

Amanda Jackson is an author at University of North Carolina at Chapel Hill specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	747
2	Health Sciences	2	2	90
3	Biochemistry	1	1	50
4	Cell Biology	1	1	29
5	Cellular Physiology	1	1	50

Amanda Jackson

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Metformin is associated with improved survival in endometrial cancer Emily Ko, Paige Walter, Amanda Jackson, Gynecologic Oncology MedicineCancer ManagementGynecologyEndometrial CancerOncology	2013	158
Robot-assisted versus open radical hysterectomy: A multi-institutional experience for early-stage cervical cancer B.M. Sert, John F. Boggess, Sarfraz Ahmad, European Journal of Surgical Oncology Gynecologic SurgerySurgical OncologyGynecological SurgeryCervical CancerCervical Health	2016	151
Detection of Sentinel Nodes for Endometrial Cancer With Robotic Assisted Fluorescence Imaging: Cervical Versus Hysteroscopic Injection Emma Rossi, Amanda Jackson, Anastasia Ivanova, International Journal of Gynecological Cancer	2013	118
JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer* Haifeng Qiu, Amanda Jackson, Joshua E. Kilgore, Oncotarget	2015	94
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study Kimberly K. Leslie, Virginia L. Filiaci, Adrianne Mallen, Gynecologic Oncology MedicineCancer ManagementGynecologyAdvanced/recurrent Endometrial CancerCancer Treatment	2021	78
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study Ignace Vergote, Els Van Nieuwenhuysen, Roisin E. O’Cearbhaill, Journal of Clinical Oncology	2023	71
Recurrence-free and 5-year survival following robotic-assisted surgical staging for endometrial carcinoma Joshua E. Kilgore, Amanda Jackson, Emily Ko, Gynecologic Oncology Robotic-assisted Surgical StagingGynecologic SurgerySurgical Oncology5-Year SurvivalGynecological Surgery	2012	66
Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells Xiaoyun Han, Xiugui Sheng, Hannah M. Jones, Journal of Hematology & Oncology Chemoprevention StrategyAerobic GlycolysisMedicinePharmacologyGynecology	2015	64
The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: Prevalence and prognostic significance Emily Ko, Paige Walter, Leslie H. Clark, Gynecologic Oncology ObesityMetabolic SyndromeCancer EpidemiologyEndocrine-related CancerDiabetes	2014	62
Cyclic AMP and free fatty acids in the longer-term regulation of pyruvate dehydrogenase kinase in rat soleus muscle Pamela B. Stace, Hasmukh R. Fatania, Amanda Jackson, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Rat Soleus MuscleEnergy MetabolismMolecular PhysiologyMuscle FunctionBiochemistry	1992	50

Page 1